ORIGINAL RESEARCH
Accepted on 07 Apr 2025
S1PR4-dependent effects of Etrasimod on primary human myeloid immune cell activation
doi 10.3389/fphar.2025.1590816
- Frontiers in Pharmacology
- Inflammation Pharmacology
- Research Topics
- Volume II: Anti-inflammatory drug development focusing on immune mediated diseases
Volume II: Anti-inflammatory drug development focusing on immune mediated diseases
432
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.